DAWN Stock-Based Compensation
Day One Biopharmaceuticals Inc · Stock-Based Compensation
DAWN Stock-Based Compensation
Latest reported$44.39Mperiod ending
DAWN TTM Stock-Based Comp ($526.00K → $44.39M)
TTM stock-based compensation
High-resolution chart · PNG
DAWN stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 44,388,000 | |
| 44,355,000 | |
| 46,348,000 | |
| 48,480,000 | |
| 48,263,000 | |
| 48,039,000 | |
| 46,091,000 | |
| 42,538,000 | |
| 39,341,000 | |
| 35,363,000 | |
| 34,333,000 | |
| 30,487,000 | |
| 27,242,000 | |
| 25,506,000 | |
| 22,079,000 | |
| 18,985,000 | |
| 13,321,000 | |
| 8,574,000 | |
| 3,485,000 | |
| 1,005,000 | |
| 526,000 |